These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

718 related items for PubMed ID: 15346546

  • 1. [Renal sequelae of sympathetic hyperactivity].
    Watschinger B, Habicht A.
    Wien Med Wochenschr; 2004; 154 Spec No 1(1):7-9. PubMed ID: 15346546
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Angiotensin-converting enzyme inhibition in renal and hypertensive disorders.
    Götz R, Heidbreder E, Heidland A.
    Clin Physiol Biochem; 1990; 8 Suppl 1():25-32. PubMed ID: 2257721
    [Abstract] [Full Text] [Related]

  • 4. Moxonidine: a new antiadrenergic antihypertensive agent.
    Prichard BN, Graham BR, Owens CW.
    J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [ACE-inhibitors in renal protection].
    Barna I.
    Orv Hetil; 2006 Jun 04; 147(22):1019-23. PubMed ID: 16913091
    [Abstract] [Full Text] [Related]

  • 7. [New central agents in the treatment of arterial hypertension].
    Robles NR.
    An Med Interna; 1999 Oct 04; 16(10):495-7. PubMed ID: 10603665
    [No Abstract] [Full Text] [Related]

  • 8. The role of sympathetic nervous activity in renal injury and end-stage renal disease.
    Masuo K, Lambert GW, Esler MD, Rakugi H, Ogihara T, Schlaich MP.
    Hypertens Res; 2010 Jun 04; 33(6):521-8. PubMed ID: 20339374
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Renovascular hypertension and beta blockers. Theoretical and practical implications].
    Guédon J, Lucsko M, Cuche JL, Chaignon M.
    Arch Mal Coeur Vaiss; 1979 Nov 04; 72 Spec no():9-15. PubMed ID: 43714
    [Abstract] [Full Text] [Related]

  • 11. [Historical perspective of renin-angiotensin system blocking in the treatment of arterial hypertension].
    Coca A, Redón J.
    Med Clin (Barc); 1996 Mar 30; 106(12):457-9. PubMed ID: 8656731
    [No Abstract] [Full Text] [Related]

  • 12. Role of the sympathetic nervous system in human renovascular hypertension.
    Johansson M, Friberg P.
    Curr Hypertens Rep; 2000 Jun 30; 2(3):319-26. PubMed ID: 10981166
    [Abstract] [Full Text] [Related]

  • 13. A comprehensive review of antihypertensive agents providing renal protection.
    Kalus JS, White CM.
    Conn Med; 2001 Oct 30; 65(10):587-91. PubMed ID: 11702517
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of hypertension.
    Cuddy ML.
    J Pract Nurs; 2006 Oct 30; 56(1):11-5; quiz 18-9. PubMed ID: 16704189
    [No Abstract] [Full Text] [Related]

  • 15. Kidney angiotensin receptors and their role in renal pathophysiology.
    Sandberg K, Ji H.
    Semin Nephrol; 2000 Sep 30; 20(5):402-16. PubMed ID: 11022892
    [Abstract] [Full Text] [Related]

  • 16. Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system.
    Hollenberg NK, Williams GH.
    Adv Intern Med; 1980 Sep 30; 25():327-61. PubMed ID: 6153859
    [No Abstract] [Full Text] [Related]

  • 17. Interaction between the renin-angiotensin and beta adrenergic nervous systems in drinking and pressor responses after renal artery constriction.
    Atkinson J, Lüthi P, Péra-Bally R, Peters-Haefeli L.
    J Pharmacol Exp Ther; 1982 May 30; 221(2):453-60. PubMed ID: 6281416
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Prospects for pharmacological effects on renin-angiotensin and sympathetic nervous systems in patients with arterial hypertension].
    Chikhladze NM.
    Ter Arkh; 2000 May 30; 72(12):67-9. PubMed ID: 11201840
    [No Abstract] [Full Text] [Related]

  • 20. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activation of the sympathetic nervous system is the dominant contributor to systemic hypertension.
    Negrao CE, Negrao MV.
    J Appl Physiol (1985); 2010 Dec 30; 109(6):2006. PubMed ID: 21188817
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.